Krishna Institute of Medical Sciences Ltd Analyst Rating
based on 13 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 13 analysts offering long term price targets for Krishna Institute of Medical Sciences Ltd. An average target of ₹593.54
Source: S&P Global Market Intelligence
Krishna Institute of Medical Sciences Ltd Share analysis
Krishna Institute of Medical Sciences Ltd price forecast by 13 analysts
Downside of
High
₹705
Target
₹593.54
Low
₹406.4
Krishna Institute of Medical Sciences Ltd target price ₹593.54, a slight downside of -0.29% compared to current price of ₹592.9. According to 13 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Krishna Institute of Medical Sciences Ltd revenue growth forecast
Expected growth rate Q1, FY2026:53.17%
Forecast
Actual
Including amortisation and stock based compensations
Krishna Institute of Medical Sciences Ltd EPS growth forecast
EPS estimate Q1, FY2026:47.23%
Forecast
Actual
Source: S&P Global Market Intelligence
Krishna Institute of Medical Sciences Ltd Performance
Day's Low
Day's High
₹588Day's Price Range₹601.8552 Week's Low
52 Week's High
₹35052-Week Price Range₹634.65
| Returns % | |
| 1 Month Return | + 1.93 % |
| 3 Month Return | + 9.38 % |
| 1 Year Return | + 50.7 % |
| Market Stats | |
| Previous Close | ₹595.25 |
| Open | ₹590.05 |
| Volume | 5.40L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹23,314.10Cr |
Krishna Institute of Medical Sciences Ltd Key Statistics
| P/E Ratio | 71.92 |
| PEG Ratio | -264.43 |
| Market Cap | ₹23,314.10 Cr |
| P/B Ratio | 8.82 |
| EPS | 8.398 |
| Dividend Yield | 0 |
| Sector | Healthcare |
| ROE | 13.46 |
Krishna Institute of Medical Sciences Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹23,314.10 Cr | 39.71% | 0.58 | ₹336 Cr | ₹2,498 Cr | |
| BUY | ₹26,168.40 Cr | 64.14% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
| BUY | ₹1,16,004.52 Cr | 191.31% | 0.53 | ₹1,057 Cr | ₹5,704 Cr | |
| BUY | ₹51,540.99 Cr | 82.67% | 0.54 | ₹645 Cr | ₹7,175 Cr | |
| BUY | ₹1,04,062.71 Cr | 85.28% | 0.65 | ₹917 Cr | ₹19,059 Cr |
About Krishna Institute of Medical Sciences Ltd
KIMS has a wide range of products, including medical equipment, pharmaceuticals, medical supplies, and medical technology. The company also offers a variety of popular brands, such as Medica, Medtronic, Siemens, and Philips. KIMS also provides services such as medical diagnostics, healthcare services, hospital management, and medical education.
Share Price: ₹592.90 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹23,314.10Cr as of today
Revenue: ₹777.30Cr as on September 2024 (Q3 24)
Net Profit: ₹120.70Cr as on September 2024 (Q3 24)
Listing date: 28 Jun, 2021
Chairperson Name: Bhaskara Rao Bollineni
| Organisation | Krishna Institute of Medical Sciences Ltd |
| Headquarters | Secunderabad |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Krishna Institute of Medical Sciences Ltd
KIMS Shares Rise Following HSBC Target Price Upgrade - 29 Nov, 2024
KIMS shares surged nearly 2% after HSBC raised its target price to ₹670, reflecting optimism in India's hospital sector and projected growth. Despite potential pressure on EBITDA margins, investor sentiment remains positive as KIMS positions for expansion in the healthcare market.KIMS Hospitals Plans Expansion and Revenue Growth - 26 Nov, 2024
KIMS Hospitals aims to increase average revenue per bed to ₹40,000 through oncology and childcare expansion. The hospital chain plans to add 1,800 beds and has reported a revenue growth to ₹773 crore for Q2 FY24, with a 57% rise in shares over the past year.KIMS Stock Shows Bullish Momentum and Growth Potential - 22 Nov, 2024
Krishna Institute of Medical Sciences (KIMS) demonstrates strong performance driven by healthcare demand in South India, with bullish technical indicators suggesting continued upward momentum.KIMS Reports Strong Growth and Revised Target Price - 12 Nov, 2024
Krishna Institute of Medical Sciences (KIMS) shows robust EBITDA growth of 27% YoY, prompting a revised target price of Rs 675/share. New leadership and clinical talent hiring across regions are expected to enhance profitability and revenue. The management anticipates a 22% EBITDA CAGR over FY24-27E, with a focus on achieving faster breakeven in new clusters. However, delays in breakeven remain a key risk.KIMS Reports Strong Q2 Results, Stock Volatile - 11 Nov, 2024
Krishna Institute of Medical Sciences (KIMS) reported strong Q2 FY25 results, with significant increases in revenue and net profit. The stock initially surged but ended lower, reflecting market volatility despite positive financial performance.KIMS Hospitals Expands Operations in Kerala - 07 Nov, 2024
Krishna Institute of Medical Sciences (KIMS) Hospitals plans to expand into Kerala, establishing 3,000 beds and creating 10,000 jobs over the next five years.KIMS Hospitals Expands Operations in Kerala - 06 Nov, 2024
KIMS Hospitals is expanding into Kerala, planning to establish 3,000 new beds over five years. The company has begun operations by acquiring Sreechand Hospital and entering an O&M contract with Westfort Hospital. Future plans include developing health cities and specialized centers in various districts.
Insights on Krishna Institute of Medical Sciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, 65.5 Cr → 107.4 Cr (in ₹), with an average increase of 21.9% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 609.09 Cr → 782.3 Cr (in ₹), with an average increase of 8.0% per quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, KIMS stock has moved up by 39.2%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 25.30% to 25.77% in Sep 2024 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 11.22% to 13.03% in Sep 2024 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 38.82% of holdings in Sep 2024 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 17.84% to 15.85% in Sep 2024 quarter
Krishna Institute of Medical Sciences Ltd Financials
Index Inclusions
Krishna Institute of Medical Sciences Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 38.82% | 0.00 | |
| Foreign Institutions | 15.85% | ||
| Mutual Funds | 25.77% | 1.86 | |
| Retail Investors | 13.03% | 16.12 | |
| Others | 6.53% |
Krishna Institute of Medical Sciences Ltd Key Indicators
Krishna Institute of Medical Sciences Ltd Valuation
Krishna Institute of Medical Sciences Ltd in the last 5 years
Lowest (6.82x)
June 30, 2021
Today (71.92x)
December 19, 2024
Industry (105.00x)
December 19, 2024
Highest (75.26x)
December 9, 2024
Krishna Institute of Medical Sciences Ltd Earnings and Dividends
Krishna Institute of Medical Sciences Ltd Earnings Results
Krishna Institute of Medical Sciences Ltd’s net profit jumped 16.71% since last year same period to ₹107.40Cr in the Q2 2024-2025. On a quarterly growth basis, Krishna Institute of Medical Sciences Ltd has generated 24.02% jump in its net profits since last 3-months.
Read More about Earnings Results
Krishna Institute of Medical Sciences Ltd Technicals Summary
Bearish
Neutral
Bullish
Krishna Institute of Medical Sciences Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Krishna Institute of Medical Sciences Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Krishna Institute of Medical Sciences Ltd shares.
Krishna Institute of Medical Sciences Ltd (KIMS) share price today is ₹592.9
Krishna Institute of Medical Sciences Ltd is listed on NSE
Krishna Institute of Medical Sciences Ltd is listed on BSE
- Today’s highest price of Krishna Institute of Medical Sciences Ltd is ₹601.85.
- Today’s lowest price of Krishna Institute of Medical Sciences Ltd is ₹588.
PE Ratio of Krishna Institute of Medical Sciences Ltd is 71.92
PE ratio = Krishna Institute of Medical Sciences Ltd Market price per share / Krishna Institute of Medical Sciences Ltd Earnings per share
Today’s traded volume of Krishna Institute of Medical Sciences Ltd(KIMS) is 5.40L.
Today’s market capitalisation of Krishna Institute of Medical Sciences Ltd(KIMS) is ₹23314.1Cr.
| Krishna Institute of Medical Sciences Ltd(KIMS | Price |
|---|---|
52 Week High | ₹634.65 |
52 Week Low | ₹350 |
Krishna Institute of Medical Sciences Ltd(KIMS) share price is ₹592.9. It is down -6.58% from its 52 Week High price of ₹634.65
Krishna Institute of Medical Sciences Ltd(KIMS) share price is ₹592.9. It is up 69.40% from its 52 Week Low price of ₹350
| Krishna Institute of Medical Sciences Ltd(KIMS | Returns |
|---|---|
1 Day Returns | -2.35% |
1 Month Returns | 1.93% |
3 Month Returns | 9.38% |
1 Year Returns | 50.7% |